WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

Alterations in ATC/DDD

Overview of ATC/DDD alterations decided at the two previous meetings of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the ATC/DDD alterations from the latest meeting (temporary codes) should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the alterations will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list. 

Please note that all ATC alterations are valid and implemented annually.

 

Change in ATC codes

INN/generic namePrevious ATC codeNew ATC codeDeadline for objection to temporary alterations 1) Implementation in ATC/DDD index
calcium acetate 2)A12AA12V03AE0701.09.20152016
ferric citrateB03AB06V03AE0801.09.20152016

Change of ATC level name

Previous nameNew ATC level nameATC codeDeadline for objection to temporary alterations Implementation in ATC/DDD index
No changes.

Change of DDDs

ATC codeLevel namePrevious DDDNew DDDDeadline for objection to temporary alterations 1) Implementation in ATC/DDD index
B01AE07dabigatran etexilate 0.22 g O0.3 g O01.09.20152016
B01AF01rivaroxaban10 mg O20 mg O01.09.20152016
B01AF02apixaban5 mg O10 mg O01.09.20152016
G03GA02Human menopausal gonadotrophin30 U P75 U P01.09.20152016
1) Final: indicates that the date for objection has expired
2) Previous ATC level name: calcium acetate anhydrous

Last updated: 2015-04-29